NASDAQ · Biotechnology

ARDX (ARDX) Stock

$5.09 +0.49% NASDAQ: ARDX Healthcare

Valuation

MetricValue
Price$5.09
Market Cap$1.26B
P/E Ratio11.04
P/B Ratio9.44
P/S Ratio3.28
EPS (TTM)$0.52
52-Week High$8.40
52-Week Low$3.49
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-39.46%
ROA-5.11%
ROCE-24.55%
Gross Margin91.93%
Operating Margin-8.75%
Net Margin-13.58%
Debt/Equity1.40
Current Ratio4.29

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$52.0M$124.0M$334.0M$407.0M
Operating Profit$-154.0M$-64.0M$-63.0M$-28.0M$-41.0M
Net Profit$-158.0M$-67.0M$-66.0M$-39.0M$-62.0M
EPS$-1.52$-0.42$-0.30$-0.17$-0.26
Op Margin-1528.6%-122.2%-50.8%-8.4%-10.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$150.0M$190.0M$298.0M$436.0M$502.0M
Total Liabilities$67.0M$92.0M$131.0M$262.0M$335.0M
Cash$72.0M$96.0M$21.0M$65.0M$68.0M
Borrowings$46.0M$36.0M$56.0M$153.0M$212.0M

Latest News

ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle Stocktwits · Jun 26, 2026 Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last? Zacks · Jun 24, 2026 Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction Motley Fool · Jun 23, 2026 What’s Fueling Optimism Around Ardelyx, Inc. (ARDX)’s Sales and Pipeline? Insider Monkey · Jun 23, 2026 Ardelyx Insider Sold Shares Worth $490,487, According to a Recent SEC Filing MT Newswires · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-153.0M$-70.0M$-90.0M$-45.0M$-42.0M
Investing Cash Flow$49.0M$18.0M$-132.0M$-19.0M$-10.0M
Financing Cash Flow$1.0M$10.0M$5.0M$-1.0M$0
Net Cash Flow$-19.0M$24.0M$-75.0M$43.0M$3.0M
Free Cash Flow$-154.0M$-70.0M$-90.0M$-46.0M$-44.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-41.17
FCF Yield-2.67%
Quick Ratio3.28
Interest Coverage-1.46
Return 1Y16.86%
Return 3Y46.99%
Return 5Y-31.11%

Ownership

Insiders Held3.28%
Institutions Held70.76%
Institutions Float Held73.16%
Institutional HolderSharesReport Date
Blackrock Inc.21,164,1322026-03-31
Millennium Management Llc17,842,3702026-03-31
State Street Corporation13,604,3072026-03-31
Vanguard Capital Management LLC10,365,5122026-03-31
Janus Henderson Group PLC8,371,2342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ARDX

ARDX is led by CEO Michael G. Raab, employs 395 people, headquartered in US, publicly traded since 2014.

ARDX stock trades at $5.09 with a market capitalization of $1.26B. The stock is valued at a price-to-earnings (P/E) ratio of 11.04, price-to-book of 9.44, price-to-sales of 3.28. Over the past 52 weeks the stock has ranged between $3.49 and $8.40, and currently trades 39.4% below its 52-week high.

On profitability, ARDX generates a return on equity (ROE) of -39.46%, return on capital employed of -24.55%, an operating margin of -8.75%, a net profit margin of -13.58%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides